Elevation Wealth Partners’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$34.6K Buy
401
+152
+61% +$12.6K 0.01% 492
2026
Q2
$16.8K Buy
249
+149
+149% +$9.93K 0.01% 647
2026
Q1
$6.28K Buy
100
+20
+25% +$1.39K ﹤0.01% 640
2025
Q4
$5.31K Buy
80
+50
+167% +$3.23K ﹤0.01% 613
2025
Q3
$2.02K Buy
+30
New +$2.37K ﹤0.01% 647

Other funds holding DXCM

Elevation Wealth Partners's DXCM Position: Q3 2026 in Review

Elevation Wealth Partners increased its DexCom (DXCM) stake by 61% in Q3 2026, buying an estimated $12.6K and bringing the position to 401 shares worth $34.6K. The position accounts for 0.01% of the portfolio, ranked #492.

Elevation Wealth Partners first reported a position in DXCM in Q3 2025 and has held it in 5 quarters since. 41 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Elevation Wealth Partners held 401 shares of DexCom worth $34.6K as of Q3 2026.
  • Elevation Wealth Partners bought 152 DexCom shares in Q3 2026, an estimated $12.6K.
  • DexCom made up 0.01% of Elevation Wealth Partners's portfolio in Q3 2026, its #492 holding.
  • Elevation Wealth Partners first reported a position in DexCom in Q3 2025 and has held it in 5 quarters since.
  • 41 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.